Q2 2025 Holdings
Filed 2025-08-15 | 95 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $126.9M | 922,958 | 8.4% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $122.9M | 6,904,302 | 8.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $80.8M | 2,243,935 | 5.3% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $62.2M | 750,000 | 4.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $60.3M | 209,794 | 4.0% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $55.6M | 3,820,158 | 3.7% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $52.0M | 5,756,805 | 3.4% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $50.1M | 2,984,733 | 3.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $49.6M | 902,304 | 3.3% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $45.2M | 12,343,351 | 3.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $40.7M | 966,740 | 2.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $40.2M | 3,011,818 | 2.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $34.8M | 106,750 | 2.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $30.5M | 8,167,100 | 2.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $29.9M | 2,185,000 | 2.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $27.6M | 2,422,833 | 1.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $27.2M | 70,000 | 1.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $26.9M | 86,250 | 1.8% |
| Neuropace Inc(NPCE) | COM | 641288105 | $25.8M | 2,312,957 | 1.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $23.6M | 42,876 | 1.6% |
| Surmodics Inc(SU6) | COM | 868873100 | $23.4M | 789,060 | 1.6% |
| Geron Corp(GERN) | COM | 374163103 | $22.8M | 16,140,000 | 1.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $22.5M | 462,811 | 1.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $19.5M | 2,119,000 | 1.3% |
| Humana Inc(HUM) | COM | 444859102 | $19.5M | 79,600 | 1.3% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $19.3M | 715,439 | 1.3% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $17.0M | 1,387,818 | 1.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $15.8M | 1,459,395 | 1.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $15.2M | 298,696 | 1.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $14.7M | 85,000 | 1.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $14.1M | 109,000 | 0.9% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $13.0M | 354,401 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $12.9M | 732,968 | 0.9% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $12.3M | 6,325,000 | 0.8% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $12.3M | 658,145 | 0.8% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $12.1M | 7,309,254 | 0.8% |
| Theratechnologies Inc(TQ80) | COM NEW | 88338H704 | $11.3M | 4,801,376 | 0.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.2M | 1,092,110 | 0.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $10.0M | 6,978,942 | 0.7% |
| Enovis Corporation(ENOV) | COM | 194014502 | $9.9M | 315,000 | 0.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $9.5M | 125,000 | 0.6% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $9.1M | 211,900 | 0.6% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $8.3M | 1,494,420 | 0.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.1M | 123,031 | 0.5% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $8.0M | 796,744 | 0.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.3M | 72,772 | 0.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $7.1M | 321,040 | 0.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $7.0M | 254,689 | 0.5% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $6.5M | 376,000 | 0.4% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $6.5M | 400,000 | 0.4% |